Repair of naturally occurring mismatches can induce mutations in flanking DNA

eLife

Volumn 2014, Issue 3, 2014, Pages

  Chen, Jia ^a   Miller, Brendan F ^a   Furano, Anthony V ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; ATR PROTEIN; CYCLINE; CYTIDINE DEAMINASE; CYTOSINE; GENOMIC DNA; PLASMID VECTOR; SMALL INTERFERING RNA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEAMINATION; DNA FLANKING REGION; DNA TRANSFECTION; EPISOME; EXCISION REPAIR; EXPRESSION VECTOR; GENE SILENCING; HUMAN; HUMAN CELL; MISMATCH REPAIR; MUTATION; MUTATOR GENE; NEOPLASM; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SHUTTLE VECTOR; SITE DIRECTED MUTAGENESIS;

EID: 84899889433     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.02001.001     Document Type: Article

References (73)

1. Andersen PL, Xu F, Xiao W. 2008. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Research 18:162-173. doi: 10.1038/cr.2007.114.
2. Atamna H, Cheung I, Ames BN. 2000. A method for detecting abasic sites in living cells: Age-dependent changes in base excision repair. Proceedings of the National Academy of Sciences of the United States of America 97:686-691. doi: 10.1073/pnas.97.2.686.
3. Barnes DE, Lindahl T. 2004. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annual Review of Genetics 38:445-476. doi: 10.1146/annurev.genet.38.072902.092448.
4. Bhutani N, Burns DM, Blau HM. 2011. DNA demethylation Dynamics. Cell 146:866-872. doi: 10.1016/j. cell.2011.08.042.
5. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. 2006. Human cancers express a mutator phenotype. Proceedings of the National Academy of Sciences of the United States of America 103:18238-18242. doi: 10.1073/ pnas.0607057103.
6. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. 2004. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Current Biology: CB 14:1392-1396. doi: 10.1016/j.cub. 2004.06.057.
7. Brown TC, Jiricny J. 1987. A specific mismatch repair event protects mammalian cells from loss of 5-methylcytosine. Cell 50:945-950. doi: 10.1016/0092-8674(87)90521-6.
8. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, Law EK, Harris RS. 2013. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494:366-370. doi: 10.1038/nature11881.
9. Burns MB, Temiz NA, Harris RS. 2013. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nature Genetics 45:977-983. doi: 10.1038/ng.2701.
10. Caldecott KW. 2008. Single-strand break repair and genetic disease. Nature Reviews Genetics 9:619-631. doi: 10.1038/nrg2380.
11. Cannavo E, Gerrits B, Marra G, Schlapbach R, Jiricny J. 2007. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. The Journal of Biological Chemistry 282:2976-2986. doi: 10.1074/ jbc.M609989200.
12. Carey MF, Peterson CL, Smale ST. 2009. Chromatin immunoprecipitation (ChIP). Cold Spring Harbor Protocols 9:doi: 10.1101/pdb.prot5279.
13. Choi J-H, Pfeifer GP. 2005. The role of DNA polymerase eta in UV mutational spectra. DNA Repair 4:211-220. doi: 10.1016/j.dnarep.2004.09.006.
14. Conticello S. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biology 9:229. doi: 10.1186/ gb-2008-9-6-229.
15. Conticello SG, Langlois MA, Yang Z, Neuberger MS. 2007. DNA deamination in immunity: AID in the context of its APOBEC relatives. Advances in Immunology 94:37-73. doi: 10.1016/S0065-2776(06)94002-4.
16. Cortázar D, Kunz C, Saito Y, Steinacher R, Schär P. 2007. The enigmatic thymine DNA glycosylase. DNA Repair 6:489-504. doi: 10.1016/j.dnarep.2006.10.013.
17. Cortez D, Guntuku S, Qin J, Elledge SJ. 2001. ATR and ATRIP: partners in checkpoint signaling. Science 294:1713-1716. doi: 10.1126/science.1065521.
18. Dèjardin J, Kingston RE. 2009. Purification of proteins associated with specific genomic Loci. Cell 136:175-186. doi: 10.1016/j.cell.2008.11.045.
19. Doehle BP, Schafer A, Cullen BR. 2005. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 339:281-288. doi: 10.1016/j.virol.2005.06.005.
20. Fijalkowska IJ, Jonczyk P, Tkaczyk MM, Bialoskorska M, Schaaper RM. 1998. Unequal fidelity of leading strand and lagging strand DNA replication on the Escherichia coli chromosome. Proceedings of the National Academy of Sciences of the United States of America 95:10020-10025. doi: 10.1073/pnas.95.17.10020.
21. Flynn RL, Zou L. 2011. ATR: a master conductor of cellular responses to DNA replication stress. Trends in Biochemical Sciences 36:133-140. doi: 10.1016/j.tibs.2010.09.005.
22. Galtier N, Gouy M, Gautier C. 1996. SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny. Computer Applications in the Biosciences 12:543-548.
23. Guo JU, Su YJ, Zhong C, Ming GL, Song HJ. 2011. Hydroxylation of 5-Methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423-434. doi: 10.1016/j.cell.2011.03.022.
24. Hanawalt PC, Spivak G. 2008. Transcription-coupled DNA repair: two decades of progress and surprises. Nature Reviews Molecular Cell Biology 9:958-970. doi: 10.1038/nrm2549.
25. Hare JT, Taylor JH. 1985. One role for DNA methylation in vertebrate cells is strand discrimination in mismatch repair. Proceedings of the National Academy of Sciences of the United States of America 82:7350-7354. doi: 10.1073/pnas.82.21.7350.
26. Hegde ML, Hazra TK, Mitra S. 2008. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Research 18:27-47. doi: 10.1038/cr.2008.8.
27. Hou EW, Prasad R, Asagoshi K, Masaoka A, Wilson SH. 2007. Comparative assessment of plasmid and oligonucleotide DNA substrates in measurement of in vitro base excision repair activity. Nucleic Acids Research 35:1-10. doi: 10.1093/nar/gkm639.
28. Hsieh P. 2012. DNA mismatch repair: Dr. Jekyll and Mr. Hyde? Molecular Cell 47:665-666. doi: 10.1016/j. molcel.2012.08.020.
29. Hsieh P, Yamane K. 2008. DNA mismatch repair: molecular mechanism, cancer, and ageing. Mechanisms of Ageing and Development 129:391-407. doi: 10.1016/j.mad.2008.02.012.
30. Huttley GA, Jakobsen IB, Wilson SR, Easteal S. 2000. How important is DNA replication for mutagenesis? Molecular Biology and Evolution 17:929-937. doi: 10.1093/oxfordjournals.molbev.a026373.
31. Hwang DG, Green P. 2004. Bayesian Markov chain Monte Carlo sequence analysis reveals varying neutral substitution patterns in mammalian evolution. Proceedings of the National Academy of Sciences of the United States of America 101:13994-14001. doi: 10.1073/pnas.0404142101.
32. Jacobs AL, Schar P. 2012. DNA glycosylases: in DNA repair and beyond. Chromosoma 121:1-20. doi: 10.1007/s00412-011-0347-4.
33. Jiricny J. 2013. Postreplicative mismatch repair. Cold Spring Harbor Perspectives in Biology 5:a012633. doi: 10.1101/cshperspect.a012633.
34. Kadyrov FA, Dzantiev L, Constantin N, Modrich P. 2006. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126:297-308. doi: 10.1016/j.cell.2006.05.039.
35. Kovtun IV, McMurray CT. 2007. Crosstalk of DNA glycosylases with pathways other than base excision repair. DNA Repair 6:517-529. doi: 10.1016/j.dnarep.2006.10.015.
36. Kunz C, Saito Y, Schar P. 2009. DNA Repair in mammalian cells: mismatched repair: variations on a theme. Cellular and Molecular Life Sciences: CMLS 66:1021-1038. doi: 10.1007/s00018-009-8739-9.
37. Lange SS, Takata K, Wood RD. 2011. DNA polymerases and cancer. Nature Reviews Cancer 11:96-110. doi: 10.1038/ nrc2998.
38. Langlois MA, Beale RC, Conticello SG, Neuberger MS. 2005. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Research 33:1913-1923. doi: 10.1093/nar/gki343.
39. Lee K-Y, Myung K. 2008. PCNA modifications for regulation of post-replication repair pathways. Molecules and Cells 26:5-11.
40. Leonard B, Hart SN, Burns MB, Carpenter MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, Li Y, Zhang Y, Maurer MJ, Oberg AL, Cunningham JM, Shridhar V, Bell DA, April C, Bentley D, Bibikova M, Cheetham RK, Fan JB, Grocock R, Humphray S, Kingsbury Z, Peden J, Chien J, Swisher EM, Hartmann LC, Kalli KR, Goode EL, Sicotte H, Kaufmann SH, Harris RS. 2013. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Research 73:7222-7231. doi: 10.1158/0008-5472.can-1113-1753.
41. Liu Y, Fang Y, Shao H, Lindsey-Boltz L, Sancar A, Modrich P. 2010. Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway. The Journal of Biological Chemistry 285:5974-5982. doi: 10.1074/jbc.M109.076109.
42. Martomo SA, Gearhart PJ. 2006. Somatic hypermutation: subverted DNA repair. Current Opinion in Immunology 18:243-248. doi: 10.1016/j.coi.2006.03.007.
43. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, Shafer A, Neri F, Lee K, Kutyavin T, Stehling-Sun S, Johnson AK, Canfield TK, Giste E, Diegel M, Bates D, Hansen RS, Neph S, Sabo PJ, Heimfeld S, Raubitschek A, Ziegler S, Cotsapas C, Sotoodehnia N, Glass I, Sunyaev SR, Kaul R, Stamatoyannopoulos JA. 2012. Systematic localization of common disease-associated variation in regulatory DNA. Science 337:1190-1195. doi: 10.1126/science.1222794.
44. Modrich P. 2006. Mechanisms in eukaryotic mismatch repair. The Journal of Biological Chemistry 281:30305-30309. doi: 10.1074/jbc.R600022200.
45. Moldovan G-L, Pfander B, Jentsch S. 2007. PCNA, the Maestro of the Replication Fork. Cell 129:665-679. doi: 10.1016/j.cell.2007.05.003.
46. Nam EA, Cortez D. 2011. ATR signalling: more than meeting at the fork. The Biochemical Journal 436:527-536. doi: 10.1042/BJ20102162.
47. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg Å, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979-993. doi: 10.1016/j.cell.2012.04.024.
48. Pabla N, Ma ZW, McIlhatton MA, Fishel R, Dong Z. 2011. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. The Journal of Biological Chemistry 286:10411-10418. doi: 10.1074/ jbc.M110.210989.
49. Parris CN, Seidman MM. 1992. A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene 117:1-5. doi: 10.1016/0378-1119(92)90482-5.
50. Pathania S, Nguyen J, Hill SJ, Scully R, Adelmant GO, Marto JA, Feunteun J, Livingston DM. 2011. BRCA1 is required for postreplication repair after UV-induced DNA damage. Molecular Cell 44:235-251. doi: 10.1016/j. molcel.2011.09.002.
51. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, Scharff MD. 2008. The biochemistry of somatic hypermutation. Annual Review of Immunology 26:481-511. doi: 10.1146/annurev.immunol.26.021607.090236.
52. Peña-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Borán M, Castor D, Lopes M, Sartori AA, Jiricny J. 2012. Noncanonical mismatch repair as a source of genomic instability in human cells. Molecular Cell 47:669-680. doi: 10.1016/j.molcel.2012.07.006.
53. Peña-Diaz J, Jiricny J. 2012. Mammalian mismatch repair: error-free or error-prone? Trends in Biochemical Sciences 37:206-214. doi: 10.1016/j.tibs.2012.03.001.
54. Pluciennik A, Dzantiev L, Iyer RR, Constantin N, Kadyrov FA, Modrich P. 2010. PCNA function in the activation and strand direction of MutLalpha endonuclease in mismatch repair. Proceedings of the National Academy of Sciences of the United States of America 107:16066-16071. doi: 10.1073/pnas.1010662107.
55. Prochnow C, Bransteitter R, Chen XS. 2009. APOBEC deaminases-mutases with defensive roles for immunity. Science in China Series C, Life Sciences/Chinese Academy of Sciences 52:893-902. doi: 10.1007/s11427-009-0133-1.
56. Qi H, Zhu H, Lou M, Fan Y, Liu H, Shen J, Li Z, Lv X, Shan J, Zhu L, Chin YE, Shao J. 2012. Interferon regulatory factor 1 transactivates expression of human DNA polymerase eta in response to carcinogen N-methyl-N'-nitro- N-nitrosoguanidine. The Journal of Biological Chemistry 287:12622-12633. doi: 10.1074/jbc.M111.313429.
57. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. 2010. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Research 38:4274-4284. doi: 10.1093/nar/gkq174.
58. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, Harris S, Shah RR, Resnick MA, Getz G, Gordenin DA. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nature Genetics 45:970-976. doi: 10.1038/ng.2702.
59. Roberts SA, Sterling J, Thompson C, Harris S, Mav D, Shah R, Klimczak LJ, Kryukov GV, Malc E, Mieczkowski PA, Resnick MA, Gordenin DA. 2012. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Molecular Cell 46:424-435. doi: 10.1016/j.molcel.2012.03.030.
60. Robertson AB. 2009. Base excision repair: the long and short of it. Cellular and Molecular Life Sciences 66:981-993. doi: 10.1007/s00018-009-8736-z.
61. Schanz S, Castor D, Fischer F, Jiricny J. 2009. Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. Proceedings of the National Academy of Sciences of the United States of America 106:5593-5598. doi: 10.1073/pnas.0901726106.
62. Seidman MM, Dixon K, Razzaque A, Zagursky RJ, Berman ML. 1985. A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene 38:233-237. doi: 10.1016/0378-1119(85)90222-7.
63. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Oslo Breast Cancer Consortium (OSBREAC), Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van 't Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR. 2012. The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400-404. doi: 10.1038/ nature11017.
64. Strauss BS. 2002. The "A" rule revisited: polymerases as determinants of mutational specificity. DNA Repair 1:125-135. doi: 10.1016/S1568-7864(01)00014-3.
65. Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, Campbell PJ, Rada C, Stratton MR, Neuberger MS. 2013. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2:e00534. doi: 10.7554/eLife.00534.
66. Teng G, Papavasiliou FN. 2007. Immunoglobulin somatic hypermutation. Annual Review of Genetics 41:107-120. doi: 10.1146/annurev.genet.41.110306.130340.
67. Terai K, Abbas T, Jazaeri AA, Dutta A. 2010. CRL4Cdt2 E3 ubiquitin ligase monoubiquitinates PCNA to Promote translesion DNA synthesis. Molecular Cell 37:143-149. doi: 10.1016/j.molcel.2009.12.018.
68. van der Kuyl A, Berkhout B. 2012. The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology 9:92-105. doi: 10.1186/1742-4690-9-92.
69. Venkatesan RN, Bielas JH, Loeb LA. 2006. Generation of mutator mutants during carcinogenesis. DNA Repair 5:294-302. doi: 10.1016/j.dnarep.2005.10.012.
70. Walser JC, Furano AV. 2010. The mutational spectrum of non-CpG DNA varies with CpG content. Genome Research 20:875-882. doi: 10.1101/gr.103283.109.
71. Wittkopp PJ, Kalay G. 2012. Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence. Nature Reviews Genetics 13:59-69. doi: 10.1038/nrg3095.
72. Wu CH, Chen S, Shortreed MR, Kreitinger GM, Yuan Y, Frey BL, Zhang Y, Mirza S, Cirillo LA, Olivier M, Smith LM. 2011. Sequence-specific capture of protein-DNA complexes for mass spectrometric protein identification. PLOS ONE 6:e26217. doi: 10.1371/journal.pone.0026217.
73. Wu H, Zhang Y. 2014. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156:45-68. doi: 10.1016/j.cell.2013.12.019.